Ursodeoxycholic Acid Therapy in Chronic Heart Failure: A Placebo-Controlled Study Evaluating the Effects of Ursodeoxycholic Acid on Peripheral Blood Flow and Immune Function.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Ursodeoxycholic acid (Primary)
- Indications Chronic heart failure
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 07 Feb 2012 Results published in the Journal of the American College of Cardiology.
- 07 Oct 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History